Background Low-density lipoprotein (LDL) 
Introduction

Since the 1970s, physicians have known that patients on renal replacement therapy have a markedly increased risk of developing cardiovascular disease (1). More recently, even minor renal dysfunction, known as chronic kidney disease (CKD), has a major impact on the cardiovascular disease risk. CKD is reflected by a decrease in the estimated glomerular filtration rate (eGFR) and/or albuminuria or trace proteinuria. Although a higher cardiovascular disease risk in patients with proteinuria has been recognized for two decades (2), the consistency and the magnitude of the cardiovascular disease risk associated with minor renal dysfunction has only recently been fully appreciated (3, 4). CKD is more likely to develop in those with conventional risk factors for cardiovascular disease, such as hypertension, diabetes, and metabolic syndrome (MetS) (5-7). Elevated total cholesterol, high non-HDL cholesterol, and low HDL in particular are reported to be significantly associated with an increased risk of developing renal dysfunction in men (8). Elevated levels of triglyceride-rich apoB-containing lipoproteins of intermediate-and low-density ranges seem to promote the progression of human renal insufficiency, whereas there was no association between the cholesterol-rich apoBcontaining lipoproteins (9). However, studies on the association between low-density lipoprotein (LDL) cholesterol, an important risk factor of cardiovascular disease, and CKD are few, and it has been reported that LDL cholesterol does not predict an increased risk of renal dysfunction
.
Methods
Subjects
Between April 1, 2008 
T a b l e 1 . B a s a l Da t a b y Ch r o n i c Ki d n e y Di s e a s e ( CKD) o r No n -CKD
n e m o w n e m D K C - n o n D K C D K C - n o n D K C 4 3 2 , 2 = n 5 1 2 = n n = 110 n = 1,
T a b l e 2 . F r e q u e n c y o f Ch r o n i c Ki d n e y Di s e a s e b y t h e Qu a r t i l e s o f L DL Ch o l e s t e r o l
Results
The baseline data are shown in F r e q u e n c y o f c h r o n i c k i d n e y d i s e a s e ( CKD) b y t h e q u a r t i l e s o f L DL c h o l e s t e r o l A: i n  t o t a l s u b j e c t s , B : e x c l u d i n g s u b j e c t s o n a n t i h y p e r l i p i d e mi c a n d / o r a n t i h y p e r t e n s i v e me d i c a t i o Table 4 Age, body mass index, systolic blood pressure, fasting glucose, triglycerides, HDL cholesterol, high-sensitivity CRP, gamma glutamyltransferase, alanine aminotransferase, LDL cholesterol, diabetes, and metabolic syndrome were used as initial independent variables. eGFR: estimated glomerular filtration rate.
shows the results of stepwise logistic regression analyses using CKD as a dependent variable and age, BMI, SBP, fasting glucose, triglycerides, HDL cholesterol, hs-CRP, GGT, ALT, LDL cholesterol, diabetes, and MetS as independent variables. LDL cholesterol was independently associated with CKD in men, but not in women. The results were similar when subjects taking antihyperlipidemic and/or T a b l e 4 . S t e p wi s e L o g i s t i c Re g r e s s i o n s Us i n g Ch r o n i c Ki d n e y Di s e a s e a s a De p e n d e n t Va r i a b l e
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antihypertensive medication were excluded. 
Discussion
The presence of altered renal function in essential hypertension and advanced heart failure and after myocardial infarction is associated with higher cardiovascular morbidity and mortality. Indices of altered renal function (e.g., microalbuminuria, increased serum creatinine concentrations, decrease in estimated creatinine clearance or overt proteinuria) are independent predictors of cardiovascular morbidity and mortality in any of the three clinical situations just mentioned (3) . MetS (14) or insulin resistance syndrome (syndrome X) (15) is also an important risk factor for cardiovascular disease. However, there are many unresolved problems regarding the definition of MetS (16) (17) (18) (19) . Obesity and MetS are associated with the increased prevalence and incidence of CKD. The prevalence of CKD increases linearly with the number of components of MetS (20, 21) , which is a significant predictor of developing CKD (6, 7) . Renal damage can be caused by each component of MetS, such as low HDL cholesterol (22) , high triglyceride levels (10, 11) , and inflammatory cytokines. Insulin resistance may cause dyslipidemia, salt retention, autonomic dysfunction, and renal hemodynamic change (23) . However, few studies have examined the relationship between LDL cholesterol, which is also an important established risk factor of cardiovascular disease, and CKD (10, 11 (9) . Therefore, the association between total cholesterol or non-HDL cholesterol and the development of renal dysfunction reported by Schaeffner et al (8) (26) . Notably, total and LDL cholesterol levels are usually within normal limits or slightly reduced in these individuals (27 
